India's Piramal Pharma gains after upbeat Q4 results
13/05/2024 07:09
** Shares of India's Piramal Pharma PIRM.NS up 6.4%,
cooling off from session-high 10.8% jump
** Drugmaker's consolidated adjusted pre-tax profit for Q4
almost trebled, helped by rise in revenue and cost tightening
** Trading volumes 7x the 30-day avg
** YTD stock had risen 15.2%
(Reporting by Hritam Mukherjee in Bengaluru)
((Hritam.Mukherjee@thomsonreuters.com;))
Recent news on Piramal Pharma (Mumbai)
See all newsBrief: Piramal Pharma (Mumbai) Says Commercial Arrangement With Bayer Pharmaceuticals To Expire On December 31, 2026
Brief: Piramal Pharma (Mumbai) Says Tax Authority Confirms Demand Of 40.6 Million Rupees And Imposes Equivalent Penalty
India's Piramal Pharma falls after US FDA observations at UK facility
Brief: Piramal Pharma Says US FDA Issues Form-483 With 7 Observations To Morpeth UK Facility
Brief: Piramal Pharma Approves Exercise Of Call Option For Acquisition Of Additional 41% Equity In Yapan Bio